title: Autologous bone marrow transplantation in relapsed HIV-related non-Hodgkin's lymphoma.
abstract: There are few reports of salvage chemotherapy for HIV-related non-Hodgkin's lymphoma (NHL). We report a relapsed HIV-related high-grade NHL which was treated successfully with ESHAP chemotherapy followed by high-dose chemotherapy and autologous bone marrow transplantation (ABMT). ABMT may later have triggered opportunistic infections in this patient.
authors.affiliation: Services d'Hématologie, Hôpital Pitié-Salpétrière, Paris, France.
authors.forename: J
authors.initials: J
authors.lastname: Gabarre
authors.forename: V
authors.initials: V
authors.lastname: Leblond
authors.forename: L
authors.initials: L
authors.lastname: Sutton
authors.forename: N
authors.initials: N
authors.lastname: Azar
authors.forename: M
authors.initials: M
authors.lastname: Jouan
authors.forename: C
authors.initials: C
authors.lastname: Boccaccio
authors.forename: H
authors.initials: H
authors.lastname: Gonzalez
authors.forename: F
authors.initials: F
authors.lastname: Charlotte
authors.forename: M
authors.initials: M
authors.lastname: Gentilini
authors.forename: J L
authors.initials: JL
authors.lastname: Binet
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000209:etiology; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D001761:Bleomycin / Q000008:administration & dosage; D016026:Bone Marrow Transplantation / Q000009:adverse effects; D002051:Burkitt Lymphoma / Q000209:etiology / Q000628:therapy*; D002945:Cisplatin / Q000008:administration & dosage / Q000009:adverse effects; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage / Q000009:adverse effects; D004317:Doxorubicin / Q000008:administration & dosage; D004379:Duodenal Neoplasms / Q000209:etiology / Q000628:therapy*; D005047:Etoposide / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D016867:Immunocompromised Host; D016483:Lymphoma, AIDS-Related / Q000209:etiology / Q000628:therapy*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage / Q000009:adverse effects; D016609:Neoplasms, Second Primary; D010198:Pancytopenia / Q000209:etiology; D012074:Remission Induction; D016879:Salvage Therapy; D013848:Thigh; D019172:Transplantation Conditioning / Q000009:adverse effects; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D003561:Cytarabine; D001761:Bleomycin; D014750:Vincristine; D005047:Etoposide; D004317:Doxorubicin; D003520:Cyclophosphamide; D002945:Cisplatin; D008775:Methylprednisolone